Cargando…
Safety and Efficacy of Topical Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: A Pilot Study
PURPOSE: Evaluate safety and efficacy of topical lotilaner ophthalmic solution, 0.25% for the treatment of Demodex blepharitis. Patients and Methods. 15 patients with Demodex blepharitis, defined as >10 collarettes on the upper lid, lid margin erythema, and Demodex density of ≥1.5 mites/lash on m...
Autores principales: | Gonzalez-Salinas, Roberto, Yeu, Elizabeth, Holdbrook, Mark, Baba, Stephanie N., Ceballos, Juan Carlos, Massaro-Corredor, Martha, Corredor-Ortega, Claudia, Ramos-Betancourt, Nallely, Quiroz-Mercado, Hugo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481060/ https://www.ncbi.nlm.nih.gov/pubmed/34603770 http://dx.doi.org/10.1155/2021/3862684 |
Ejemplares similares
-
Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1)
por: Yeu, Elizabeth, et al.
Publicado: (2023) -
Psychosocial Impact of Demodex Blepharitis
por: O’Dell, Leslie, et al.
Publicado: (2022) -
Lotilaner Ophthalmic Solution 0.25%: First Approval
por: Syed, Yahiya Y.
Publicado: (2023) -
Efficacy of Topical Ivermectin 1% in the Treatment of Demodex Blepharitis
por: Choi, Young, et al.
Publicado: (2022) -
Correction to: Lotilaner Ophthalmic Solution 0.25%: First Approval
por: Syed, Yahiya Y.
Publicado: (2023)